Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate

Author:

Addetia AminORCID,Crawford Katharine HDORCID,Dingens AdamORCID,Zhu Haiying,Roychoudhury Pavitra,Huang Meei-Li,Jerome Keith R.,Bloom Jesse D.ORCID,Greninger Alexander L.ORCID

Abstract

AbstractThe development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans. However, to date, studies on protective immunity have only been performed in animal models and correlates of protection have not been established in humans. Here, we describe an outbreak of SARS-CoV-2 on a fishing vessel associated with a high attack rate. Predeparture serological and viral RT-PCR testing along with repeat testing after return to shore was available for 120 of the 122 persons on board over a median follow-up of 32.5 days (range 18.8 to 50.5 days). A total of 104 individuals had an RT-PCR positive viral test with Ct <35 or seroconverted during the follow-up period, yielding an attack rate on board of 85.2% (104/122 individuals). Metagenomic sequencing of 39 viral genomes suggested the outbreak originated largely from a single viral clade. Only three crewmembers tested seropositive prior to the boat’s departure in initial serological screening and also had neutralizing and spike-reactive antibodies in follow-up assays. None of these crewmembers with neutralizing antibody titers showed evidence of bona fide viral infection or experienced any symptoms during the viral outbreak. Therefore, the presence of neutralizing antibodies from prior infection was significantly associated with protection against re-infection (Fisher’s exact test, p=0.002).

Publisher

Cold Spring Harbor Laboratory

Reference50 articles.

1. Corbett KS , Flynn B , Foulds KE , Francica JR , Boyoglu-Barnum S , Werner AP , Flach B , O’Connell S , Bock KW , Minai M , Nagata BM , Andersen H , Martinez DR , Noe AT , Douek N , Donaldson MM , Nji NN , Alvarado GS , Edwards DK , Flebbe DR , Lamb E , Doria-Rose NA , Lin BC , Louder MK , O’Dell S , Schmidt SD , Phung E , Chang LA , Yap C , Todd J-PM , Pessaint L , Van Ry A , Browne S , Greenhouse J , Putman-Taylor T , Strasbaugh A , Campbell T-A , Cook A , Dodson A , Steingrebe K , Shi W , Zhang Y , Abiona OM , Wang L , Pegu A , Yang ES , Leung K , Zhou T , Teng I-T , Widge A , Gordon I , Novik L , Gillespie RA , Loomis RJ , Moliva JI , Stewart-Jones G , Himansu S , Kong W-P , Nason MC , Morabito KM , Ruckwardt TJ , Ledgerwood JE , Gaudinski MR , Kwong PD , Mascola JR , Carfi A , Lewis MG , Baric RS , McDermott A , Moore IN , Sullivan NJ , Roederer M , Seder RA , Graham BS . 2020. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. New England Journal of Medicine 0:null.

2. van Doremalen N , Lambe T , Spencer A , Belij-Rammerstorfer S , Purushotham JN , Port JR , Avanzato VA , Bushmaker T , Flaxman A , Ulaszewska M , Feldmann F , Allen ER , Sharpe H , Schulz J , Holbrook M , Okumura A , Meade-White K , Pérez-Pérez L , Edwards NJ , Wright D , Bissett C , Gilbride C , Williamson BN , Rosenke R , Long D , Ishwarbhai A , Kailath R , Rose L , Morris S , Powers C , Lovaglio J , Hanley PW , Scott D , Saturday G , de Wit E , Gilbert SC , Munster VJ . 2020. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature 1-8.

3. Development of an inactivated vaccine candidate for SARS-CoV-2

4. A human monoclonal antibody blocking SARS-CoV-2 infection

5. Ju B , Zhang Q , Ge J , Wang R , Sun J , Ge X , Yu J , Shan S , Zhou B , Song S , Tang X , Yu J , Lan J , Yuan J , Wang H , Zhao J , Zhang S , Wang Y , Shi X , Liu L , Zhao J , Wang X , Zhang Z , Zhang L . 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature https://doi.org/10.1038/s41586-020-2380-z.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3